Zydus gets USFDA nod, brings cheaper cancer drug to India

January 23, 2026
Uncategorized

Zydus Lifesciences Ltd completed USFDA inspection at Ankleshwar with three observations. Shares of Zydus Lifesciences Ltd ended lower on Friday, January 23, by 0.26% at 883.00 on the NSE.

Zydus gets USFDA nod, brings cheaper cancer drug to India

Leave a ReplyCancel Reply

MMTC-PAMP to launch silver recycling pilot in 3 months amid supply concern

Q3 earnings, US Fed interest rate decision, Budget to steer market movement: Analysts

Hindustan Copper declared preferred bidder for Baghwari-Khirkhori copper block in Madhya Pradesh

Dhanlaxmi Bank Q3 net profit surges 20% to ₹24 crore; gross NPA falls

Hitachi Energy India faces ₹26 crore tax demand for AY 2022-23, to appeal with ITAT